CEPAEDEX Trademark

Trademark Overview


On Thursday, June 13, 2013, a trademark application was filed for CEPAEDEX with the United States Patent and Trademark Office. The USPTO has given the CEPAEDEX trademark a serial number of 85959272. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, August 27, 2021. This trademark is owned by GW Pharma Limited. The CEPAEDEX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and veterinary preparations and substances for the treatment of epilepsy, convulsions, seizures, pain, multiple sclerosis, neuropathic pain, spinal cord injury, bladder disfunction, peripheral neuropathy, cancer pain, peri-operative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, crohns disease, alzheimers, bone disorders, drug, alcohol and nicotine abuse and inflammatory disorders; pharmaceutical preparations and substances for the treatment of pediatric epilepsy; pharmaceutical and veterinary preparations and substances for the treatment of Dravet syndrome, hypoxic-ischaemic encephalopathy, Lennox-Gastaut s...
cepaedex

General Information


Serial Number85959272
Word MarkCEPAEDEX
Filing DateThursday, June 13, 2013
Status710 - CANCELLED - SECTION 8
Status DateFriday, August 27, 2021
Registration Number4673758
Registration DateTuesday, January 20, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 13, 2014

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesPharmaceutical and veterinary preparations and substances for the treatment of epilepsy, convulsions, seizures, pain, multiple sclerosis, neuropathic pain, spinal cord injury, bladder disfunction, peripheral neuropathy, cancer pain, peri-operative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, crohns disease, alzheimers, bone disorders, drug, alcohol and nicotine abuse and inflammatory disorders; pharmaceutical preparations and substances for the treatment of pediatric epilepsy; pharmaceutical and veterinary preparations and substances for the treatment of Dravet syndrome, hypoxic-ischaemic encephalopathy, Lennox-Gastaut syndrome (LGS), intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, and Doose syndrome; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions for the treatment of epilepsy, convulsions, seizures, pain, multiple sclerosis, neuropathic pain, spinal cord injury, bladder disfunction, peripheral neuropathy, cancer pain, peri-operative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, crohns disease, alzheimers, bone disorders, hypoxic-ischaemic encephalopathy, drug, alcohol and nicotine abuse and inflammatory disorders; pure extracts of medicinal plants and herbs used for the treatment of epilepsy, convulsions, seizures, pain, multiple sclerosis, neuropathic pain, spinal cord injury, bladder disfunction, peripheral neuropathy, cancer pain, peri-operative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, crohns disease, alzheimers, hypoxic-ischaemic encephalopathy, bone disorders, drug, alcohol and nicotine abuse and inflammatory disorders; herb teas for medicinal purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, August 27, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGW RESEARCH LIMITED
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressCAMBRIDGE CB249BZ
GB

Party NameGW Pharma Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge CB249BZ
GB

Party NameGW Pharma Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSalisbury SP4OJR
GB

Party NameGW Pharma Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSalisbury SP4OJR
GB

Trademark Events


Event DateEvent Description
Wednesday, September 15, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 15, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, September 15, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 15, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 27, 2021CANCELLED SEC. 8 (6-YR)
Wednesday, July 28, 2021ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, January 20, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, July 25, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, December 12, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, December 12, 2017TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, November 29, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 29, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 20, 2015REGISTERED-PRINCIPAL REGISTER
Wednesday, October 8, 20141(B) BASIS DELETED; PROCEED TO REGISTRATION
Sunday, September 21, 2014NOTICE OF ALLOWANCE CANCELLED
Tuesday, October 7, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sunday, September 21, 2014TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, July 8, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 13, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 13, 2014PUBLISHED FOR OPPOSITION
Wednesday, April 23, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, April 10, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, April 8, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 7, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 7, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 31, 2014ASSIGNED TO LIE
Tuesday, March 18, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 18, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 18, 2013NON-FINAL ACTION E-MAILED
Wednesday, September 18, 2013NON-FINAL ACTION WRITTEN
Sunday, September 15, 2013ASSIGNED TO EXAMINER
Friday, June 21, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, June 17, 2013NEW APPLICATION ENTERED IN TRAM